Eastwood Bio Gross Profit vs. Price To Sales
| EBM Stock | CAD 0.54 0.11 16.92% |
Gross Profit | First Reported 2013-07-31 | Previous Quarter 113.6 K | Current Value 59.8 K | Quarterly Volatility 72.1 K |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.4 | 0.57 |
|
|
For Eastwood Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eastwood Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eastwood Bio Medical Canada utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eastwood Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eastwood Bio Medical Canada over time as well as its relative position and ranking within its peers.
Eastwood |
Eastwood Bio Medical Price To Sales vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Eastwood Bio's current stock value. Our valuation model uses many indicators to compare Eastwood Bio value to that of its competitors to determine the firm's financial worth. Eastwood Bio Medical Canada is one of the top stocks in gross profit category among its peers. It also is one of the top stocks in price to sales category among its peers . The ratio of Gross Profit to Price To Sales for Eastwood Bio Medical Canada is about 15,860 . At this time, Eastwood Bio's Gross Profit is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eastwood Bio's earnings, one of the primary drivers of an investment's value.Eastwood Price To Sales vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Eastwood Bio |
| = | 902.74 K |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Eastwood Bio |
| = | 56.92 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Eastwood Price To Sales Comparison
Eastwood Bio is currently under evaluation in price to sales category among its peers.
Eastwood Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Eastwood Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Eastwood Bio will eventually generate negative long term returns. The profitability progress is the general direction of Eastwood Bio's change in net profit over the period of time. It can combine multiple indicators of Eastwood Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 8.6 K | 7.6 K | |
| Operating Income | -455.4 K | -478.2 K | |
| Net Loss | -491.9 K | -516.5 K | |
| Income Before Tax | -491.9 K | -516.5 K | |
| Total Other Income Expense Net | -36.5 K | -38.3 K | |
| Net Loss | -134.9 K | -141.6 K | |
| Net Loss | -491.9 K | -516.5 K | |
| Income Tax Expense | (1.15) | (1.21) | |
| Net Interest Income | -25.3 K | -24.1 K | |
| Change To Netincome | 5.3 K | 5.1 K | |
| Net Loss | (0.01) | (0.01) | |
| Income Quality | 0.03 | 0.03 |
Eastwood Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Eastwood Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eastwood Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eastwood Bio's important profitability drivers and their relationship over time.
Use Eastwood Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eastwood Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eastwood Bio will appreciate offsetting losses from the drop in the long position's value.Eastwood Bio Pair Trading
Eastwood Bio Medical Canada Pair Trading Analysis
The ability to find closely correlated positions to Eastwood Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eastwood Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eastwood Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eastwood Bio Medical Canada to buy it.
The correlation of Eastwood Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eastwood Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eastwood Bio Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eastwood Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Eastwood Bio position
In addition to having Eastwood Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small & Mid Caps ETFs Thematic Idea Now
Small & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small & Mid Caps ETFs theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio's price analysis, check to measure Eastwood Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio is operating at the current time. Most of Eastwood Bio's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio's price. Additionally, you may evaluate how the addition of Eastwood Bio to your portfolios can decrease your overall portfolio volatility.